• LAST PRICE
    38.8000
  • TODAY'S CHANGE (%)
    Trending Down-0.1800 (-0.4618%)
  • Bid / Lots
    38.5000/ 1
  • Ask / Lots
    62.3800/ 2
  • Open / Previous Close
    39.1000 / 38.9800
  • Day Range
    Low 38.5100
    High 39.5700
  • 52 Week Range
    Low 27.9850
    High 50.9900
  • Volume
    418,657
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 38.98
TimeVolumeXENE
09:32 ET329839.2224
09:48 ET30039.24
09:50 ET245139.25
09:52 ET76339.1527
09:54 ET13639.42
09:57 ET40039.22
10:06 ET10039.21
10:14 ET702439.065
10:15 ET10039.085
10:17 ET56938.97
10:19 ET180838.965
10:21 ET570738.96
10:24 ET149139.08
10:26 ET20039.09
10:28 ET31039
10:30 ET20038.97
10:32 ET255839.085
10:33 ET20039.1
10:35 ET103939.1275
10:37 ET20039.06
10:39 ET10039.06
10:42 ET10039.05
10:44 ET10039.015
10:50 ET10039
10:51 ET10038.92
10:53 ET40038.91
10:55 ET20038.88
10:57 ET20038.91
11:02 ET10038.85
11:04 ET10038.82
11:06 ET20038.79
11:09 ET20038.79
11:11 ET100038.855
11:15 ET10038.8
11:18 ET20838.825
11:20 ET80038.94
11:22 ET40038.97
11:24 ET44438.94
11:29 ET110038.86
11:31 ET40038.83
11:33 ET10038.92
11:40 ET137538.83
11:42 ET45038.82
11:44 ET40038.77
11:45 ET20038.82
11:47 ET80038.82
11:49 ET135138.82
11:51 ET70038.84
11:54 ET10038.82
11:56 ET20038.83
11:58 ET11038.82
12:00 ET20038.82
12:02 ET20038.79
12:07 ET20038.82
12:09 ET243039.11
12:12 ET90039.06
12:14 ET10039.06
12:16 ET20039.03
12:18 ET10039.04
12:20 ET130038.9
12:21 ET10038.9
12:23 ET80038.9
12:25 ET900138.89
12:27 ET121138.9
12:32 ET149639.03
12:34 ET160039.125
12:36 ET565139.15
12:38 ET40139.195
12:39 ET2116139.09
12:41 ET30039.14
12:43 ET20039.165
12:45 ET3312039.425
12:48 ET857039.31
12:52 ET460039.365
12:54 ET487239.41
12:56 ET91639.42
12:57 ET1493139.3
12:59 ET558039.36
01:01 ET20039.41
01:03 ET530039.3
01:06 ET141939.35
01:08 ET250039.35
01:10 ET914439.345
01:12 ET139839.37
01:14 ET150039.51
01:15 ET30039.57
01:17 ET43839.57
01:19 ET150039.5
01:21 ET90039.395
01:28 ET320939.34
01:32 ET30039.32
01:33 ET60039.295
01:37 ET10039.32
01:39 ET60039.21
01:46 ET155039.09
01:50 ET60039.25
01:55 ET120039.145
02:02 ET78739.065
02:06 ET10039.07
02:09 ET154238.99
02:11 ET10839.05
02:13 ET50039.09
02:18 ET40039.1063
02:22 ET60039.06
02:24 ET20039.04
02:26 ET81739.08
02:27 ET20039.05
02:29 ET10039.11
02:31 ET60039.11
02:33 ET30039.17
02:38 ET60039.12
02:40 ET10039.09
02:44 ET10039.08
02:45 ET246338.985
02:49 ET30038.99
02:54 ET10039
02:56 ET10039.04
02:58 ET10039
03:00 ET90039
03:02 ET130839.085
03:03 ET40039.13
03:07 ET10039.195
03:09 ET30039.195
03:12 ET10039.21
03:16 ET100039.16
03:18 ET55939.17
03:20 ET100039.055
03:21 ET40039.04
03:23 ET40039
03:25 ET30038.97
03:27 ET130038.96
03:30 ET22838.99
03:32 ET10038.99
03:34 ET20038.99
03:36 ET460038.75
03:38 ET274838.68
03:39 ET220838.61
03:41 ET348038.62
03:43 ET180038.56
03:45 ET210038.55
03:48 ET453338.65
03:50 ET364938.6
03:52 ET327538.69
03:54 ET559638.685
03:56 ET786938.75
03:57 ET1095338.84
03:59 ET3317738.8
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesXENE
Xenon Pharmaceuticals Inc
2.9B
-14.3x
---
United StatesIOVA
Iovance Biotherapeutics Inc
2.9B
-5.7x
---
United StatesAPGE
Apogee Therapeutics Inc
2.9B
-23.4x
---
United StatesDYN
Dyne Therapeutics Inc
2.9B
-8.0x
---
United StatesSMMT
Summit Therapeutics Inc
3.1B
-26.5x
---
United StatesRNA
Avidity Biosciences Inc
2.8B
-10.0x
---
As of 2024-05-22

Company Information

Xenon Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company focused on developing therapeutics to improve the lives of patients with neurological disorders, with a focus on epilepsy. The Company’s product pipeline includes XEN1101 (Focal Onset Seizures), XEN1101 (Primary Generalized Tonic-Clonic Seizures), XEN1101 (Major Depressive Disorder) and NBI-921352 (NEUROCRINE). It is developing XEN1101, a differentiated Kv7 potassium channel opener, for the treatment of epilepsy, MDD and potentially other neurological disorders. Its XEN1101 Phase III epilepsy program includes two identical Phase III clinical trials, called X-TOLE2 and X-TOLE3, that are designed closely after the Phase IIb X-TOLE clinical trial. Its Phase III X-ACKT clinical trial is intended to support potential regulatory submissions in an additional epilepsy indication of primary generalized tonic-clonic seizures (PGTCS).

Contact Information

Headquarters
3650 Gilmore WayVANCOUVER, BC, Canada V5G 4W8
Phone
604-484-3300
Fax
604-484-3450

Executives

Chairman of the Board
Simon Pimstone
President, Chief Executive Officer, Director
Ian Mortimer
Chief Financial Officer
Sherry Aulin
Executive Vice President - Drug Discovery
James Empfield
Executive Vice President - Strategy and Innovation
Robin Sherrington

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$2.9B
Revenue (TTM)
$0.00
Shares Outstanding
75.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.22
EPS
$-2.71
Book Value
$12.31
P/E Ratio
-14.3x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.